ABBV vs USNA · P/E 81, rev $16.99B vs P/E 18, rev $473.5M
AbbVie Inc (ABBV) versus USANA Health Sciences Inc (USNA) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
USANA Health Sciences Inc (USNA) is a packaged foods company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported USNA revenue for 2026-07-04 was $473.5M. Net income was -$13.9M. Revenue was up 89.2% from 2026-04-04 to 2026-07-04. USNA currently screens at market cap $610.3M and trailing P/E 18.0.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. USNA currently screens at market cap $610.3M and trailing P/E 18.0.
Not investment advice. Open the ABBV and USNA stock pages for the full models.
Not investment advice.